These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 10424589)

  • 1. Complement inhibition attenuates human lung transplant reperfusion injury: a multicenter trial.
    Zamora MR; Davis RD; Keshavjee SH; Schulman L; Levin J; Ryan U; Patterson GA
    Chest; 1999 Jul; 116(1 Suppl):46S. PubMed ID: 10424589
    [No Abstract]   [Full Text] [Related]  

  • 2. TP20 is superior to TP10 in reducing ischemia/reperfusion injury in rat lung grafts.
    Schmid RA; Hillinger S; Hamacher J; Stammberger U
    Transplant Proc; 2001; 33(1-2):948-9. PubMed ID: 11267139
    [No Abstract]   [Full Text] [Related]  

  • 3. A randomized, placebo-controlled trial of complement inhibition in ischemia-reperfusion injury after lung transplantation in human beings.
    Keshavjee S; Davis RD; Zamora MR; de Perrot M; Patterson GA
    J Thorac Cardiovasc Surg; 2005 Feb; 129(2):423-8. PubMed ID: 15678055
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Strategies for targeting complement inhibitors in ischaemia/reperfusion injury.
    Dong J; Pratt JR; Smith RA; Dodd I; Sacks SH
    Mol Immunol; 1999; 36(13-14):957-63. PubMed ID: 10698350
    [TBL] [Abstract][Full Text] [Related]  

  • 5. sCR1sLe(X) reduces lung allograft ischemia-reperfusion injury but does not ameliorate acute rejection.
    Stammberger U; Hamacher J; Pache JC; Schmid RA
    Eur J Cardiothorac Surg; 2002 Sep; 22(3):368-72. PubMed ID: 12204725
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Soluble complement component tackles reperfusion injury.
    Fricker J
    Mol Med Today; 1997 Oct; 3(10):413. PubMed ID: 9358464
    [No Abstract]   [Full Text] [Related]  

  • 7. Role of complement and perspectives for intervention in transplantation.
    Chen G; Chen S; Chen X
    Immunobiology; 2013 May; 218(5):817-27. PubMed ID: 23182708
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A blockade of complement activation prevents rapid intestinal ischaemia-reperfusion injury by modulating mucosal mast cell degranulation in rats.
    Kimura T; Andoh A; Fujiyama Y; Saotome T; Bamba T
    Clin Exp Immunol; 1998 Mar; 111(3):484-90. PubMed ID: 9528887
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Complement inhibition in renal diseases.
    Inal JM; Pascual M; Lesavre P; Schifferli JA
    Nephrol Dial Transplant; 2003 Feb; 18(2):237-40. PubMed ID: 12543873
    [No Abstract]   [Full Text] [Related]  

  • 10. The complement system in myocardial ischaemia/reperfusion injury.
    Kilgore KS; Friedrichs GS; Homeister JW; Lucchesi BR
    Cardiovasc Res; 1994 Apr; 28(4):437-44. PubMed ID: 8181029
    [No Abstract]   [Full Text] [Related]  

  • 11. Aprotinin decreases reperfusion injury and allograft dysfunction in clinical lung transplantation.
    Bittner HB; Richter M; Kuntze T; Rahmel A; Dahlberg P; Hertz M; Mohr FW
    Eur J Cardiothorac Surg; 2006 Feb; 29(2):210-5. PubMed ID: 16386921
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The future use of complement inhibitors for the treatment of neurological diseases.
    McGeer EG; McGeer PL
    Drugs; 1998 Jun; 55(6):739-46. PubMed ID: 9617589
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of the complement cascade in ischemia/reperfusion injury: implications for neuroprotection.
    D'Ambrosio AL; Pinsky DJ; Connolly ES
    Mol Med; 2001 Jun; 7(6):367-82. PubMed ID: 11474130
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of soluble complement receptor type 1 on reperfusion edema and neutrophil migration after lung allotransplantation in swine.
    Schmid RA; Zollinger A; Singer T; Hillinger S; Leon-Wyss JR; Schöb OM; Høgåsen K; Zünd G; Patterson GA; Weder W
    J Thorac Cardiovasc Surg; 1998 Jul; 116(1):90-7. PubMed ID: 9671902
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of angiotensin-converting enzyme by captopril: a novel approach to reduce ischemia-reperfusion injury after lung transplantation.
    Fischer S; Maclean AA; Liu M; Kalirai B; Keshavjee S
    J Thorac Cardiovasc Surg; 2000 Sep; 120(3):573-80. PubMed ID: 10962421
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ischemia/reperfusion injury: effect of simultaneous inhibition of plasma cascade systems versus specific complement inhibition.
    Duehrkop C; Rieben R
    Biochem Pharmacol; 2014 Mar; 88(1):12-22. PubMed ID: 24384116
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Complement in ischemia reperfusion injury.
    Riedemann NC; Ward PA
    Am J Pathol; 2003 Feb; 162(2):363-7. PubMed ID: 12547694
    [No Abstract]   [Full Text] [Related]  

  • 18. Controlled pulmonary reperfusion: what is the optimal method of delivery?
    Allen BS
    Ann Thorac Surg; 2000 Oct; 70(4):1449-50. PubMed ID: 11081931
    [No Abstract]   [Full Text] [Related]  

  • 19. APT070 (Mirococept), a membrane-localised complement inhibitor, inhibits inflammatory responses that follow intestinal ischaemia and reperfusion injury.
    Souza DG; Esser D; Bradford R; Vieira AT; Teixeira MM
    Br J Pharmacol; 2005 Aug; 145(8):1027-34. PubMed ID: 15951831
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular studies of the immunological effects of the sevoflurane preconditioning in the liver and lung in a rat model of liver ischemia/reperfusion injury.
    Mikrou A; Kalimeris KA; Lilis I; Papoutsidakis N; Nastos K; Papadaki H; Kostopanagiotou GG; Zarkadis IK
    Mol Immunol; 2016 Apr; 72():1-8. PubMed ID: 26922039
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.